NCT00001212View on ClinicalTrials.gov

Drug Therapy in Lupus Nephropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 30, 1986

Study Completion Date

September 30, 2004

Conditions
Nephrotic SyndromeSystemic Lupus Erythematosus
Interventions
DRUG

prednisone

DRUG

cyclophosphamide

DRUG

cyclosporin A

Trial Locations (1)

20892

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00001212 - Drug Therapy in Lupus Nephropathy | Biotech Hunter | Biotech Hunter